Tavo and Pembrolizumab With or Without Chemotherapy in Patients With Inoperable Locally Advanced or Metastatic TNBC

NCT03567720 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

65

Enrollment

INDUSTRY

Sponsor class

Conditions

Triple Negative Breast Cancer

Interventions

BIOLOGICAL: tavokinogene telseplasmid
BIOLOGICAL: Pembrolizumab
DEVICE: Immunopulse
DRUG: nab paclitaxel
DRUG: gemcitabine plus carboplatin

Sponsor

OncoSec Medical Incorporated

Collaborators

[object Object]